We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
226
Lumen
LUMN
$6.53B
$3.8M 0.09%
138,633
+7,998
+6% +$233K
EXEL icon
227
Exelixis
EXEL
$13.9B
$3.77M 0.09%
+295,000
New +$3.19M
WBA
228
DELISTED
Walgreens Boots Alliance
WBA
$3.77M 0.09%
46,727
+11,786
+34% +$961K
RL icon
229
Ralph Lauren
RL
$22.2B
$3.77M 0.09%
+37,224
New +$3.74M
MDCO
230
DELISTED
Medicines Co
MDCO
$3.74M 0.09%
99,000
+24,000
+32% +$904K
AGEN
231
Agenus
AGEN
$249M
$3.72M 0.09%
26,377
+3,057
+13% +$350K
TSRO
232
DELISTED
TESARO, Inc.
TSRO
$3.71M 0.09%
37,000
-64,500
-64% -$6.03M
TNL icon
233
Travel + Leisure Co
TNL
$4.54B
$3.66M 0.09%
+120,465
New +$3.85M
WWAV
234
DELISTED
The WhiteWave Foods Company
WWAV
$3.66M 0.09%
67,286
-55,524
-45% -$3.06M
GS icon
235
Goldman Sachs
GS
$313B
$3.65M 0.09%
22,644
+3,362
+17% +$547K
VNDA icon
236
Vanda Pharmaceuticals
VNDA
$312M
$3.61M 0.09%
+217,000
New +$2.92M
TSLA icon
237
Tesla
TSLA
$1.24T
$3.6M 0.09%
264,480
-286,365
-52% -$4.13M
AEE icon
238
Ameren
AEE
$31.5B
$3.58M 0.09%
72,794
+35,699
+96% +$1.82M
RARE icon
239
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.55M 0.09%
50,000
-10,000
-17% -$638K
KMB icon
240
Kimberly-Clark
KMB
$36.4B
$3.54M 0.09%
28,096
+6,695
+31% +$866K
ICPT
241
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.54M 0.09%
21,500
-1,500
-7% -$236K
EQT icon
242
EQT Corp
EQT
$33.2B
$3.53M 0.08%
89,309
+4,656
+6% +$184K
LXRX icon
243
Lexicon Pharmaceuticals
LXRX
$1.02B
$3.52M 0.08%
195,000
+67,000
+52% +$1.08M
PNC icon
244
PNC Financial Services
PNC
$100B
$3.47M 0.08%
38,563
+16,773
+77% +$1.44M
NKTR icon
245
Nektar Therapeutics
NKTR
$2.39B
$3.44M 0.08%
13,333
-6,867
-34% -$1.77M
XLRN
246
DELISTED
Acceleron Pharma
XLRN
$3.4M 0.08%
94,000
+14,000
+18% +$464K
LH icon
247
Labcorp
LH
$24.3B
$3.4M 0.08%
28,758
+23,059
+405% +$2.72M
N
248
DELISTED
Netsuite Inc
N
$3.34M 0.08%
+30,210
New +$3.04M
INTU icon
249
Intuit
INTU
$81.1B
$3.33M 0.08%
30,269
+2,677
+10% +$299K
KHC icon
250
Kraft Heinz
KHC
$30.4B
$3.33M 0.08%
37,195
+6,180
+20% +$547K

Similar funds

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.